LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia

By Branger Judith  

International Immunology, Vol. 16, Iss. 11, 2004-11 ,pp. : 1605-1611

Oxford University Press

Access to resources Recommend Favorite

Synergy between LPS and immobilized anti-human CD3 mAb for activation of cord blood CD3+ T cells

By Goldberg Michael R.   Luknar-Gabor Noemi   Zadik-Mnuhin Galia   Koch Penina   Tovbin Joseph   Katz Yitzhak  

International Immunology, Vol. 19, Iss. 1, 2007-01 ,pp. : 99-103

Oxford University Press

Access to resources Recommend Favorite

Recognition of Pneumococcal Peptidoglycan - An Expanded, Pivotal Role for LPS Binding Protein

By Weber J.R.   Freyer D.   Alexander C.   Schroder N.W.J.   Reiss A.   Kuster C.   Pfeil D.   Tuomanen E.I.   Schumann R.R.  

Immunity, Vol. 19, Iss. 2, 2003-08 ,pp. : 269-279

Elsevier

Access to resources Recommend Favorite

Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS

By Dueñas Ana I   Aceves Mónica   Orduña Antonio   Díaz Ramón   Sánchez Crespo Mariano   García-Rodríguez Carmen  

International Immunology, Vol. 18, Iss. 5, 2006-05 ,pp. : 785-795

Oxford University Press

Access to resources Recommend Favorite

Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells

By Suzuki Kaori   Murakami Taisuke   Kuwahara-Arai Kyoko   Tamura Hiroshi   Hiramatsu Keiichi   Nagaoka Isao  

International Immunology, Vol. 23, Iss. 3, 2011-03 ,pp. : 185-193

Oxford University Press

Access to resources Recommend Favorite